Journal of Cancer Research and Therapeutics Close
 

Figure 2: Tumor composed of oligodendrocytes showing pleomorphism, endothelial hyperplasia, and necrosis (inset) (H and E; 160)

Figure 2: Tumor composed of oligodendrocytes showing pleomorphism, endothelial hyperplasia, and necrosis (inset) (H and E; 160)